{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:43:24Z","timestamp":1790649804443,"version":"4.1.0"},"reference-count":157,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Inherited retinal diseases (IRDs) are a heterogenous group of orphan eye diseases that typically result from monogenic mutations and are considered attractive targets for gene-based therapeutics. Following the approval of an IRD gene replacement therapy for Leber\u2019s congenital amaurosis due to <jats:italic>RPE65<\/jats:italic> mutations, there has been an intensive international research effort to identify the optimal gene therapy approaches for a range of IRDs and many are now undergoing clinical trials. In this review we explore therapeutic challenges posed by IRDs and review current and future approaches that may be applicable to different subsets of IRD mutations. Emphasis is placed on five distinct approaches to gene-based therapy that have potential to treat the full spectrum of IRDs: 1) gene replacement using adeno-associated virus (AAV) and nonviral delivery vectors, 2) genome editing via the CRISPR\/Cas9 system, 3) RNA editing by endogenous and exogenous ADAR, 4) mRNA targeting with antisense oligonucleotides for gene knockdown and splicing modification, and 5) optogenetic approaches that aim to replace the function of native retinal photoreceptors by engineering other retinal cell types to become capable of phototransduction.<\/jats:p>","DOI":"10.3389\/fgene.2021.794805","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T05:15:53Z","timestamp":1641532553000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Gene-Based Therapeutics for Inherited Retinal Diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Beau J.","family":"Fenner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-En","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amutha Veluchamy","family":"Barathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Bo Bo","family":"Tun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sia Wey","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S. H.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Yen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chui Ming Gemmy","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choi Mun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodhbir S.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin Y. C.","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1167\/iovs.14-16274","article-title":"Lipofuscin Redistribution and Loss Accompanied by Cytoskeletal Stress in Retinal Pigment Epithelium of Eyes with Age-Related Macular Degeneration","volume":"56","author":"Ach","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature06310","article-title":"Neural Substrates of Awakening Probed with Optogenetic Control of Hypocretin Neurons","volume":"450","author":"Adamantidis","year":"2007","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ejpb.2014.12.028","article-title":"Nanoparticle-Based Technologies for Retinal Gene Therapy","volume":"95","author":"Adijanto","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41433-020-01286-z","article-title":"Adaptive Optics: Principles and Applications in Ophthalmology","volume":"35","author":"Akyol","year":"2021","journal-title":"Eye"},{"key":"B5","doi-asserted-by":"publisher","first-page":"819760","DOI":"10.1155\/2015\/819760","article-title":"Retinitis Pigmentosa with EYS Mutations Is the Most Prevalent Inherited Retinal Dystrophy in Japanese Populations","volume":"2015","author":"Arai","year":"2015","journal-title":"J. Ophthalmol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mgg3.109","article-title":"Novel Insights into the Molecular Pathogenesis of CYP 4V2 \u2010associated Bietti's Retinal Dystrophy","volume":"3","author":"Astuti","year":"2015","journal-title":"Mol. Genet. Genomic Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.10.002","article-title":"The Molecular and Cellular Basis of Rhodopsin Retinitis Pigmentosa Reveals Potential Strategies for Therapy","volume":"62","author":"Athanasiou","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.survophthal.2017.09.009","article-title":"Treatment of Cystoid Macular Edema Secondary to Retinitis Pigmentosa: a Systematic Review","volume":"63","author":"Bakthavatchalam","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/1566523214666140302193709","article-title":"Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy","volume":"14","author":"Balakrishnan","year":"2014","journal-title":"Cgt"},{"key":"B10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ymgme.2021.07.010","article-title":"A Review of Treatment Modalities in Gyrate Atrophy of the Choroid and Retina (GACR)","volume":"134","author":"Balfoort","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1093\/hmg\/ddy179","article-title":"Basal Exon Skipping and Nonsense-Associated Altered Splicing Allows Bypassing Complete CEP290 Loss-Of-Function in Individuals with Unusually Mild Retinal Disease","volume":"27","author":"Barny","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-030-28471-8_3","article-title":"Developing Cell-Based Therapies for RPE-Associated Degenerative Eye Diseases","volume":"1186","author":"Ben M'Barek","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/tvst.6.4.15","article-title":"Dark-Adapted Chromatic Perimetry for Measuring Rod Visual Fields in Patients with Retinitis Pigmentosa","volume":"6","author":"Bennett","year":"2017","journal-title":"Trans. Vis. Sci. Tech."},{"key":"B14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic Antisense Oligonucleotides Are Coming of Age","volume":"70","author":"Bennett","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0002-9394(85)90351-4","article-title":"Natural Course of Retinitis Pigmentosa over a Three-Year Interval","volume":"99","author":"Berson","year":"1985","journal-title":"Am. J. Ophthalmol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuron.2006.02.026","article-title":"Ectopic Expression of a Microbial-type Rhodopsin Restores Visual Responses in Mice with Photoreceptor Degeneration","volume":"50","author":"Bi","year":"2006","journal-title":"Neuron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ophtha.2008.12.019","article-title":"Central Areolar Choroidal Dystrophy","volume":"116","author":"Boon","year":"2009","journal-title":"Ophthalmology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/icu.0000000000000647","article-title":"Vision 2020: where Are We?","volume":"31","author":"Bourne","year":"2020","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.ymthe.2017.05.015","article-title":"Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration","volume":"25","author":"Burnight","year":"2017","journal-title":"Mol. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.preteyeres.2018.03.003","article-title":"CRISPR-Cas9 Genome Engineering: Treating Inherited Retinal Degeneration","volume":"65","author":"Burnight","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e135112","DOI":"10.1172\/jci.insight.135112","article-title":"In Vivo-directed Evolution of Adeno-Associated Virus in the Primate Retina","volume":"5","author":"Byrne","year":"2020","journal-title":"JCI Insight"},{"key":"B22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajhg.2016.12.003","article-title":"Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease","volume":"100","author":"Carss","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3389\/fnins.2017.00503","article-title":"Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting","volume":"11","author":"Carvalho","year":"2017","journal-title":"Front. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41525-021-00180-1","article-title":"Genetic Characteristics and Epidemiology of Inherited Retinal Degeneration in Taiwan","volume":"6","author":"Chen","year":"2021","journal-title":"Npj Genom. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.drudis.2017.01.013","article-title":"Safety of Antisense Oligonucleotide and siRNA-Based Therapeutics","volume":"22","author":"Chi","year":"2017","journal-title":"Drug Discov. Today"},{"key":"B26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/ceo.13022","article-title":"Novel Mobility Test to Assess Functional Vision in Patients with Inherited Retinal Dystrophies","volume":"46","author":"Chung","year":"2018","journal-title":"Clin. Exp. Ophthalmol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40123-020-00241-1","article-title":"Reviewing the Role of Ultra-Widefield Imaging in Inherited Retinal Dystrophies","volume":"9","author":"Cicinelli","year":"2020","journal-title":"Ophthalmol. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41591-021-01297-7","article-title":"Durable Vision Improvement after a Single Treatment with Antisense Oligonucleotide Sepofarsen: a Case Report","volume":"27","author":"Cideciyan","year":"","journal-title":"Nat. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/annurev-vision-032321-091738","article-title":"Measures of Function and Structure to Determine Phenotypic Features, Natural History, and Treatment Outcomes in Inherited Retinal Diseases","volume":"7","author":"Cideciyan","year":"","journal-title":"Annu. Rev. Vis. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.preteyeres.2010.04.004","article-title":"Nanoparticles for Retinal Gene Therapy","volume":"29","author":"Conley","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"100861","DOI":"10.1016\/j.preteyeres.2020.100861","article-title":"Clinical Spectrum, Genetic Complexity and Therapeutic Approaches for Retinal Disease Caused by ABCA4 Mutations","volume":"79","author":"Cremers","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular Uptake and Trafficking of Antisense Oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1136\/bjophthalmol-2021-319228","article-title":"Structural Evaluation in Inherited Retinal Diseases","volume":"105","author":"Daich Varela","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"a017129","DOI":"10.1101\/cshperspect.a017129","article-title":"Genes and Mutations Causing Autosomal Dominant Retinitis Pigmentosa","volume":"5","author":"Daiger","year":"2014","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","article-title":"In Vivo-directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nmeth.f.324","article-title":"Optogenetics","volume":"8","author":"Deisseroth","year":"2011","journal-title":"Nat. Methods"},{"key":"B37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/icu.0000000000000392","article-title":"Choroideremia","volume":"28","author":"Dimopoulos","year":"2017","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/icu.0000000000000140","article-title":"Optogenetics","volume":"26","author":"Duebel","year":"2015","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.ymthe.2021.04.024","article-title":"Antisense Oligonucleotide-Based Treatment of Retinitis Pigmentosa Caused by USH2A Exon 13 Mutations","volume":"29","author":"Dulla","year":"2021","journal-title":"Mol. Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"eaan4672","DOI":"10.1126\/science.aan4672","article-title":"Gene Therapy Comes of Age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"B41","first-page":"691","article-title":"The Co-Occurrence of Rare Non-ocular Phenotypes in Patients with Inherited Retinal Degenerations","volume":"25","author":"Ehrenberg","year":"2019","journal-title":"Mol. Vis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/978-1-0716-0787-9_14","article-title":"Proteome Diversification by RNA Editing","volume":"2181","author":"Eisenberg","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.oret.2019.11.010","article-title":"X-Chromosome Inactivation Is a Biomarker of Clinical Severity in Female Carriers of RPGR-Associated X-Linked Retinitis Pigmentosa","volume":"4","author":"Fahim","year":"2020","journal-title":"Ophthalmol. Retina"},{"key":"B44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/gt.2011.172","article-title":"Gene-based Therapies for Dominantly Inherited Retinopathies","volume":"19","author":"Farrar","year":"2012","journal-title":"Gene Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3390\/ijms21030777","article-title":"RNA Editing as a Therapeutic Approach for Retinal Gene Therapy Requiring Long Coding Sequences","volume":"21","author":"Fry","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"6723","DOI":"10.3390\/ijms22136723","article-title":"Usher Syndrome: Genetics of a Human Ciliopathy","volume":"22","author":"Fuster-Garc\u00eda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00439-017-1837-0","article-title":"ADAR RNA Editing in Human Disease; More to it Than Meets the I","volume":"136","author":"Gallo","year":"2017","journal-title":"Hum. Genet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2147\/opth.s241928","article-title":"The Impact of Inherited Retinal Diseases in the Republic of Ireland (ROI) and the United Kingdom (UK) from a Cost-Of-Illness Perspective","volume":"14","author":"Galvin","year":"2020","journal-title":"Opth"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.ophtha.2019.04.038","article-title":"Genetic and Clinical Findings in a Large Cohort of Chinese Patients with Suspected Retinitis Pigmentosa","volume":"126","author":"Gao","year":"2019","journal-title":"Ophthalmology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1038\/s41467-020-19344-1","article-title":"A Catalogue of Biochemically Diverse CRISPR-Cas9 Orthologs","volume":"11","author":"Gasiunas","year":"2020","journal-title":"Nat. Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of Blindness and Vision Impairment in 2020 and Trends over 30 years, and Prevalence of Avoidable Blindness in Relation to VISION 2020: the Right to Sight: an Analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1136\/bjophthalmol-2017-311328","article-title":"Adaptive Optics Imaging of Inherited Retinal Diseases","volume":"102","author":"Georgiou","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.21037\/aes-20-81","article-title":"Retinal Imaging in Inherited Retinal Diseases","volume":"5","author":"Georgiou","year":"2020","journal-title":"Ann. Eye Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"108553","DOI":"10.1016\/j.exer.2021.108553","article-title":"ON-bipolar Cell Gene Expression during Retinal Degeneration: Implications for Optogenetic Visual Restoration","volume":"207","author":"Gilhooley","year":"2021","journal-title":"Exp. Eye Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41433-019-0474-3","article-title":"Cellular Imaging of Inherited Retinal Diseases Using Adaptive Optics","volume":"33","author":"Gill","year":"2019","journal-title":"Eye"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.2147\/opth.s313719","article-title":"The Impact of Inherited Retinal Diseases in the United States of America (US) and Canada from a Cost-Of-Illness Perspective","volume":"15","author":"Gong","year":"2021","journal-title":"Opth"},{"key":"B57","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1097\/00006982-200512001-00045","article-title":"The Food and Drug Administration's Office of Orphan Products Development: Incentives, grants, and Special Designations Speed Therapies for Orphan Diseases","volume":"25","author":"Haffner","year":"2005","journal-title":"Retina"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-1172-2-7","article-title":"Cone Rod Dystrophies","volume":"2","author":"Hamel","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1089\/hum.2020.043","article-title":"Retinal Tropism and Transduction of Adeno-Associated Virus Varies by Serotype and Route of Delivery (Intravitreal, Subretinal, or Suprachoroidal) in Rats","volume":"31","author":"Han","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1073\/pnas.1913179117","article-title":"Worldwide Carrier Frequency and Genetic Prevalence of Autosomal Recessive Inherited Retinal Diseases","volume":"117","author":"Hanany","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/s0140-6736(06)69740-7","article-title":"Retinitis Pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1089\/hum.2014.2530","article-title":"Retinal Gene Therapy Using Adeno-Associated Viral Vectors: Multiple Applications for a Small Virus","volume":"25","author":"Hauswirth","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/13816810.2021.1913610","article-title":"Inherited Retinal Diseases Are the Most Common Cause of Blindness in the Working-Age Population in Australia","volume":"42","author":"Heath Jeffery","year":"2021","journal-title":"Ophthalmic Genet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/aos.14218","article-title":"Inherited Retinal Disease in Norway - a Characterization of Current Clinical and Genetic Knowledge","volume":"98","author":"Holtan","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/08164622.2021.1880863","article-title":"Gene Therapy for Inherited Retinal Diseases: Progress and Possibilities","volume":"104","author":"Hu","year":"2021","journal-title":"Clin. Exp. Optom."},{"key":"B66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/08820538.2016.1228404","article-title":"Management of Cystoid Macular Edema in Retinitis Pigmentosa","volume":"32","author":"Huckfeldt","year":"2017","journal-title":"Semin. Ophthalmol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4939-7522-8_9","article-title":"Methods for In Vivo CRISPR\/Cas Editing of the Adult Murine Retina","volume":"1715","author":"Hung","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.ymthe.2006.03.005","article-title":"Safety of Recombinant Adeno-Associated Virus Type 2-RPE65 Vector Delivered by Ocular Subretinal Injection","volume":"13","author":"Jacobson","year":"","journal-title":"Mol. Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/hum.2006.17.845","article-title":"Safety in Nonhuman Primates of Ocular AAV2-RPE65, a Candidate Treatment for Blindness in Leber Congenital Amaurosis","volume":"17","author":"Jacobson","year":"","journal-title":"Hum. Gene Ther."},{"key":"B70","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas9 Structures and Mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annu. Rev. Biophys."},{"key":"B71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.preteyeres.2017.01.006","article-title":"Bestrophin 1 and Retinal Disease","volume":"58","author":"Johnson","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1167\/iovs.12-10230","article-title":"Characterization of Pupil Responses to Blue and Red Light Stimuli in Autosomal Dominant Retinitis Pigmentosa Due toNR2E3Mutation","volume":"53","author":"Kawasaki","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/jmedgenet-2018-105691","article-title":"Genetic Characteristics of Retinitis Pigmentosa in 1204 Japanese Patients","volume":"56","author":"Koyanagi","year":"2019","journal-title":"J. Med. Genet."},{"key":"B74","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering Adeno-Associated Virus Vectors for Gene Therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e004015","DOI":"10.1136\/bmjopen-2013-004015","article-title":"A Comparison of the Causes of Blindness Certifications in England and Wales in Working Age Adults (16-64 Years), 1999-2000 with 2009-2010","volume":"4","author":"Liew","year":"2014","journal-title":"BMJ Open"},{"key":"B76","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12920-021-00874-6","article-title":"Whole-Exome Sequencing in 168 Korean Patients with Inherited Retinal Degeneration","volume":"14","author":"Ma","year":"2021","journal-title":"BMC Med. Genomics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-genom-083118-015043","article-title":"Gene and Induced Pluripotent Stem Cell Therapy for Retinal Diseases","volume":"20","author":"Maeda","year":"2019","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"B78","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a Gene-Editing Approach to Restore Vision Loss in Leber Congenital Amaurosis Type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/nejmoa0802315","article-title":"Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/s0140-6736(09)61836-5","article-title":"Age-dependent Effects of RPE65 Gene Therapy for Leber's Congenital Amaurosis: a Phase 1 Dose-Escalation Trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, Safety, and Durability of Voretigene Neparvovec-Rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy","volume":"126","author":"Maguire","year":"2019","journal-title":"Ophthalmology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.ophtha.2021.03.031","article-title":"Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 3 and 4 Years","volume":"128","author":"Maguire","year":"2021","journal-title":"Ophthalmology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-0716-0771-8_3","article-title":"Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers","volume":"2176","author":"Maruyama","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/bf00143087","article-title":"Properties of Electroretinographic Intensity-Response Functions in Retinitis Pigmentosa","volume":"57","author":"Massof","year":"1984","journal-title":"Doc Ophthalmol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1089\/hum.2018.156","article-title":"An AAV Dual Vector Strategy Ameliorates the Stargardt Phenotype in AdultAbca4\u2212\/\u2212Mice","volume":"30","author":"McClements","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"B86","doi-asserted-by":"publisher","first-page":"570909","DOI":"10.3389\/fnins.2020.570909","article-title":"Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances","volume":"14","author":"McClements","year":"2020","journal-title":"Front. Neurosci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1167\/iovs.16-19302","article-title":"Automated Light- and Dark-Adapted Perimetry for Evaluating Retinitis Pigmentosa: Filling a Need to Accommodate Multicenter Clinical Trials","volume":"57","author":"McGuigan","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/j.ymthe.2020.08.012","article-title":"Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa","volume":"28","author":"Meng","year":"2020","journal-title":"Mol. Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41587-019-0013-6","article-title":"Precise RNA Editing by Recruiting Endogenous ADARs with Antisense Oligonucleotides","volume":"37","author":"Merkle","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/357455a0","article-title":"Human Gene Therapy Comes of Age","volume":"357","author":"Miller","year":"1992","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/s0140-6736(18)31550-2","article-title":"Age-Related Macular Degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"B92","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-biochem-060208-105251","article-title":"Functions and Regulation of RNA Editing by ADAR Deaminases","volume":"79","author":"Nishikura","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"B93","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s40123-020-00287-1","article-title":"Treatment-Emergent Adverse Events in Gene Therapy Trials for Inherited Retinal Diseases: A Narrative Review","volume":"9","author":"Nuzbrokh","year":"2020","journal-title":"Ophthalmol. Ther."},{"key":"B94","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front. Endocrinol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1167\/iovs.14-15458","article-title":"Comprehensive Molecular Diagnosis of a Large Cohort of Japanese Retinitis Pigmentosa and Usher Syndrome Patients by Next-Generation Sequencing","volume":"55","author":"Oishi","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cell.2007.06.028","article-title":"The Mirtron Pathway Generates microRNA-Class Regulatory RNAs in Drosophila","volume":"130","author":"Okamura","year":"2007","journal-title":"Cell"},{"key":"B97","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1038\/s41467-021-25204-3","article-title":"Mirtron-Mediated RNA Knockdown\/replacement Therapy for the Treatment of Dominant Retinitis Pigmentosa","volume":"12","author":"Orlans","year":"2021","journal-title":"Nat. Commun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ajhg.2021.01.006","article-title":"Allele-specific Editing Ameliorates Dominant Retinitis Pigmentosa in a Transgenic Mouse Model","volume":"108","author":"Patrizi","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.3390\/ijms21072329","article-title":"CRISPR Interference-Potential Application in Retinal Disease","volume":"21","author":"Peddle","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-030-27378-1_15","article-title":"In Vivo Assessment of Potential Therapeutic Approaches for USH2A-Associated Diseases","volume":"1185","author":"Pendse","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3390\/biom11081179","article-title":"Therapy Approaches for Stargardt Disease","volume":"11","author":"Piotter","year":"2021","journal-title":"Biomolecules"},{"key":"B102","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.122.4.615","article-title":"VISION 2020: The Right to Sight: A Global Initiative to Eliminate Avoidable Blindness","volume":"122","author":"Pizzarello","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.ophtha.2020.04.008","article-title":"Genetic Basis of Inherited Retinal Disease in a Molecularly Characterized Cohort of More Than 3000 Families from the United Kingdom","volume":"127","author":"Pontikos","year":"2020","journal-title":"Ophthalmology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/icu.0000000000000660","article-title":"Gene Therapy beyond Luxturna: a New Horizon of the Treatment for Inherited Retinal Disease","volume":"31","author":"Prado","year":"2020","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/gt.2014.57","article-title":"Retinal Transduction Profiles by High-Capacity Viral Vectors","volume":"21","author":"Puppo","year":"2014","journal-title":"Gene Ther."},{"key":"B106","doi-asserted-by":"publisher","first-page":"647400","DOI":"10.3389\/fgene.2021.647400","article-title":"Identification of Deep-Intronic Splice Mutations in a Large Cohort of Patients With Inherited Retinal Diseases","volume":"12","author":"Qian","year":"2021","journal-title":"Front. Genet."},{"key":"B107","doi-asserted-by":"publisher","first-page":"12489","DOI":"10.1073\/pnas.1809432115","article-title":"Targeted Exon Skipping of a CEP290 Mutation Rescues Joubert Syndrome Phenotypes In Vitro and in a Murine Model","volume":"115","author":"Ramsbottom","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome Engineering Using the CRISPR-Cas9 System","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"101000","DOI":"10.1016\/j.preteyeres.2021.101000","article-title":"Full-field Stimulus Testing: Role in the Clinic and as an Outcome Measure in Clinical Trials of Severe Childhood Retinal Disease","author":"Roman","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.05.001","article-title":"Causes and Consequences of Inherited Cone Disorders","volume":"42","author":"Roosing","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA Precursors that Bypass Drosha Processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"key":"B113","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fneur.2019.00076","article-title":"Chromatic Pupillometry Methods for Assessing Photoreceptor Health in Retinal and Optic Nerve Diseases","volume":"10","author":"Rukmini","year":"2019","journal-title":"Front. Neurol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0140-6736(17)31868-8","article-title":"Efficacy and Safety of Voretigene Neparvovec (AAV2-hRPE65v2) in Patients with RPE65 -Mediated Inherited Retinal Dystrophy: a Randomised, Controlled, Open-Label, Phase 3 Trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"B115","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/978-3-319-75402-4_62","article-title":"Maintaining Cone Function in Rod-Cone Dystrophies","volume":"1074","author":"Sahel","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"a017111","DOI":"10.1101\/cshperspect.a017111","article-title":"Clinical Characteristics and Current Therapies for Inherited Retinal Degenerations","volume":"5","author":"Sahel","year":"2014","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41591-021-01351-4","article-title":"Partial Recovery of Visual Function in a Blind Patient after Optogenetic Therapy","volume":"27","author":"Sahel","year":"2021","journal-title":"Nat. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/wco.0b013e3283218807","article-title":"Update on Usher Syndrome","volume":"22","author":"Saihan","year":"2009","journal-title":"Curr. Opin. Neurol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/s0140-6736(14)61376-3","article-title":"Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium in Patients with Age-Related Macular Degeneration and Stargardt's Macular Dystrophy: Follow-Up of Two Open-Label Phase 1\/2 Studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"key":"B120","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/09286580802105814","article-title":"Prevalence of Retinitis Pigmentosa in South Indian Population Aged above 40 Years","volume":"15","author":"Sen","year":"2008","journal-title":"Ophthalmic Epidemiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/humu.23903","article-title":"A Nationwide Genetic Analysis of Inherited Retinal Diseases in Israel as Assessed by the Israeli Inherited Retinal Disease Consortium (IIRDC)","volume":"41","author":"Sharon","year":"2020","journal-title":"Hum. Mutat."},{"key":"B122","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1146\/annurev-pharmtox-010818-021050","article-title":"Therapeutic Oligonucleotides: State of the Art","volume":"59","author":"Smith","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1080\/14712598.2017.1347629","article-title":"Genome Editing: the Breakthrough Technology for Inherited Retinal Disease?","volume":"17","author":"Smith","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/s0161-6420(02)01756-6","article-title":"Fundus Autofluorescence and Age-Related Macular Degeneration","volume":"110","author":"Spaide","year":"2003","journal-title":"Ophthalmology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.exer.2005.01.007","article-title":"RPE Lipofuscin and its Role in Retinal Pathobiology","volume":"80","author":"Sparrow","year":"2005","journal-title":"Exp. Eye Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.coviro.2016.08.003","article-title":"In Vivo tissue-tropism of Adeno-Associated Viral Vectors","volume":"21","author":"Srivastava","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.ophtha.2017.04.008","article-title":"Clinically Focused Molecular Investigation of 1000 Consecutive Families with Inherited Retinal Disease","volume":"124","author":"Stone","year":"2017","journal-title":"Ophthalmology"},{"key":"B128","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ymthe.2019.09.010","article-title":"Non-viral Gene Therapy for Stargardt Disease with ECO\/pRHO-ABCA4 Self-Assembled Nanoparticles","volume":"28","author":"Sun","year":"2020","journal-title":"Mol. Ther."},{"key":"B129","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/diagnostics10100779","article-title":"Syndromic Inherited Retinal Diseases: Genetic, Clinical and Diagnostic Aspects","volume":"10","author":"Tatour","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"B130","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jconrel.2020.10.028","article-title":"Ocular Barriers to Retinal Delivery of Intravitreal Liposomes: Impact of Vitreoretinal Interface","volume":"328","author":"Tavakoli","year":"2020","journal-title":"J. Control. Release"},{"key":"B131","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1167\/iovs.18-24333","article-title":"Surgical Removal of Internal Limiting Membrane and Layering of AAV Vector on the Retina under Air Enhances Gene Transfection in a Nonhuman Primate","volume":"59","author":"Teo","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"108330","DOI":"10.1016\/j.exer.2020.108330","article-title":"USH2A-Retinopathy: From Genetics to Therapeutics","volume":"201","author":"Toualbi","year":"2020","journal-title":"Exp. Eye Res."},{"key":"B133","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1093\/hmg\/ddz130","article-title":"Has Retinal Gene Therapy Come of Age? from Bench to Bedside and Back to Bench","volume":"28","author":"Trapani","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"B134","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-4939-7522-8_11","article-title":"Dual AAV Vectors for Stargardt Disease","volume":"1715","author":"Trapani","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/genes10040289","article-title":"Vitro Gene Delivery in Retinal Pigment Epithelium Cells by Plasmid DNA-Wrapped Gold Nanoparticles","volume":"10","author":"Trigueros","year":"2019","journal-title":"Genes (Basel)"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.ophtha.2018.04.001","article-title":"Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa","volume":"125","author":"Tsai","year":"2018","journal-title":"Ophthalmology"},{"key":"B137","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-3-319-95046-4_27","article-title":"Stargardt Disease","volume":"1085","author":"Tsang","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/biom11050760","article-title":"A Systematic Review and Meta-Analyses of Interventional Clinical Trial Studies for Gene Therapies for the Inherited Retinal Degenerations (IRDs)","volume":"11","author":"Tuohy","year":"2021","journal-title":"Biomolecules"},{"key":"B139","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/gim.2017.97","article-title":"Mapping the Genomic Landscape of Inherited Retinal Disease Genes Prioritizes Genes Prone to Coding and Noncoding Copy-Number Variations","volume":"20","author":"Van Schil","year":"2018","journal-title":"Genet. Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic Retinitis Pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"B141","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/genes9070360","article-title":"Application of Whole Exome and Targeted Panel Sequencing in the Clinical Molecular Diagnosis of 319 Chinese Families with Inherited Retinal Dystrophy and Comparison Study","volume":"9","author":"Wang","year":"2018","journal-title":"Genes (Basel)"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/humu.24064","article-title":"Genetic Architecture of Inherited Retinal Degeneration in Germany: A Large Cohort Study from a Single Diagnostic center over a 9\u2010year Period","volume":"41","author":"Weisschuh","year":"2020","journal-title":"Hum. Mutat."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","article-title":"Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema:Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial","volume":"123","author":"Wells","year":"2016","journal-title":"Ophthalmology"},{"key":"B144","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1089\/hum.2017.179","article-title":"Assessment of Adeno-Associated Virus Serotype Tropism in Human Retinal Explants","volume":"29","author":"Wiley","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"B145","doi-asserted-by":"publisher","first-page":"16287","DOI":"10.1073\/pnas.1317033110","article-title":"Optogenetics","volume":"110","author":"Williams","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.gene.2013.03.137","article-title":"History of Gene Therapy","volume":"525","author":"Wirth","year":"2013","journal-title":"Gene"},{"key":"B147","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","article-title":"Diabetic Retinopathy","volume":"2","author":"Wong","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B148","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","article-title":"Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy","volume":"14","author":"Wu","year":"2006","journal-title":"Mol. Ther."},{"key":"B149","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/icu.0b013e3283641f91","article-title":"Lyonization in Ophthalmology","volume":"24","author":"Wuthisiri","year":"2013","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1167\/iovs.61.6.56","article-title":"Visual Field Progression in Retinitis Pigmentosa","volume":"61","author":"Xu","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1080\/13543784.2020.1804853","article-title":"Antisense Oligonucleotide Therapeutics in Clinical Trials for the Treatment of Inherited Retinal Diseases","volume":"29","author":"Xue","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B152","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1038\/s41598-020-62119-3","article-title":"Genetic Spectrum of EYS-Associated Retinal Disease in a Large Japanese Cohort: Identification of Disease-Associated Variants with Relatively High Allele Frequency","volume":"10","author":"Yang","year":"2020","journal-title":"Sci. Rep."},{"key":"B153","doi-asserted-by":"publisher","first-page":"e1081","DOI":"10.1002\/mgg3.1081","article-title":"Prevalence of Mutations in Inherited Retinal Diseases: A Comparison between the United States and India","volume":"8","author":"Yohe","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"key":"B154","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.preteyeres.2014.09.001","article-title":"Congenital Stationary Night Blindness: an Analysis and Update of Genotype-Phenotype Correlations and Pathogenic Mechanisms","volume":"45","author":"Zeitz","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.cell.2011.12.004","article-title":"The Microbial Opsin Family of Optogenetic Tools","volume":"147","author":"Zhang","year":"2011","journal-title":"Cell"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1038\/mtna.2015.37","article-title":"Off-target Effects in CRISPR\/Cas9-mediated Genome Engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"B157","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/jcp.30064","article-title":"CRISPR\/Cas Gene Therapy","volume":"236","author":"Zhang","year":"2021","journal-title":"J. Cel. Physiol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.794805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T05:15:58Z","timestamp":1641532558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.794805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":157,"alternative-id":["10.3389\/fgene.2021.794805"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.794805","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"article-number":"794805"}}